Published in Thromb Haemost on August 31, 1976
Carnitine metabolism in the fasting rat. J Biol Chem (1978) 1.75
Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. Circulation (1995) 1.74
Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation (1990) 1.60
Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation (1993) 1.43
Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75. Cancer (1984) 1.32
Relationship between acid-soluble carnitine and coenzyme A pools in vivo. Biochem J (1980) 1.31
Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: alterations with disease. Eur J Appl Physiol Occup Physiol (1999) 1.21
Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol (1985) (1996) 1.16
Inhibition of cobalamin-dependent enzymes by cobalamin analogues in rats. J Clin Invest (1991) 1.03
Skeletal muscle mitochondrial DNA injury in patients with unilateral peripheral arterial disease. Circulation (1999) 1.02
Carnitine and acylcarnitine metabolism during exercise in humans. Dependence on skeletal muscle metabolic state. J Clin Invest (1989) 1.00
An inherited qualitative abnormality in plasma fibrinogen: fibrinogen Cleveland. J Lab Clin Med (1968) 0.99
Enzymatic conversion of salicylate to salicylurate. Mol Pharmacol (1971) 0.99
Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75. JAMA (1981) 0.97
Effect of carnitine on mitochondrial oxidation of palmitoylearnitine. Biochem J (1980) 0.96
Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease. J Appl Physiol (1985) (1992) 0.95
Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas. J Clin Invest (1973) 0.94
Effect of alpha-ketobutyrate on palmitic acid and pyruvate metabolism in isolated rat hepatocytes. Biochim Biophys Acta (1986) 0.93
Carnitine metabolism during exercise in patients with peripheral vascular disease. J Appl Physiol (1985) (1987) 0.92
Abnormalities of blood coagulation tests in patients with cancer. Am J Clin Pathol (1987) 0.92
Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease. J Appl Physiol (1985) (1999) 0.92
Treatment of haemophilia (factor-8 deficiency) with human antihaemophilic factor prepared by the cryoprecipitate process. Lancet (1967) 0.92
Consolidation and maintenance therapy in multiple myeloma: randomized comparison of a new approach to therapy after initial response to treatment. J Clin Oncol (1986) 0.91
Inhibition of glucagon-stimulated hepatic glycogenolysis by E-series prostaglandins. FEBS Lett (1984) 0.91
Carnitine metabolism during exercise in patients on chronic hemodialysis. Kidney Int (1992) 0.90
Criteria for the differentiation of dysfibrinogenemic states. Semin Hematol (1976) 0.90
Effect of E-series prostaglandins on cyclic AMP-dependent and -independent hormone-stimulated glycogenolysis in hepatocytes. Diabetes (1985) 0.90
Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studies. Am J Clin Oncol (1984) 0.89
Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of Cancer. Cancer (1979) 0.89
Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects. Diabetes (1992) 0.89
Diffuse pulmonary infection due to Strongyloides stercoralis. JAMA (1974) 0.87
Kinetics of prostaglandin E metabolism in isolated hepatocytes. Biochim Biophys Acta (1984) 0.87
Interactions of propionate and carnitine metabolism in isolated rat hepatocytes. Metabolism (1987) 0.86
Nonsynthetizing multiple myeloma. Haematologia (Budap) (1977) 0.85
Quantification of carnitine, acetylcarnitine, and total carnitine in tissues by high-performance liquid chromatography: the effect of exercise on carnitine homeostasis in man. Anal Biochem (1995) 0.85
Identification and induction of cytochrome P450 2E1 in rat Kupffer cells. J Pharmacol Exp Ther (1991) 0.84
Inhibition of oxidative metabolism by propionic acid and its reversal by carnitine in isolated rat hepatocytes. Biochem J (1986) 0.84
Decreased hepatic glycogen content and accelerated response to starvation in rats with carbon tetrachloride-induced cirrhosis. Hepatology (1991) 0.84
Effect of nonsteroidal anti-inflammatory drugs on glycogenolysis in isolated hepatocytes. Br J Pharmacol (1985) 0.83
Inhibition of hepatic propionyl-CoA synthetase activity by organic acids. Reversal of propionate inhibition of pyruvate metabolism. Biochem Pharmacol (1991) 0.83
Disassociation between acidinsoluble acylcarnitines and ketogenesis following carnitine administration in vivo. J Biol Chem (1978) 0.83
Coupling of hepatic prostaglandin receptors to adenylate cyclase through a pertussis toxin sensitive guanine nucleotide regulatory protein. J Pharmacol Exp Ther (1989) 0.83
Fibrin formation: effect of calcium ions. Blood (1978) 0.83
Tumor conference: the role of continuing medical education. J Contin Educ Health Prof (1988) 0.82
Increased hepatic mitochondrial capacity in rats with hydroxy-cobalamin[c-lactam]-induced methylmalonic aciduria. J Clin Invest (1990) 0.82
Transdermal fentanyl disposition in elderly subjects. Gerontology (1994) 0.82
Periorbital ecchymoses as the initial sign in multiple myeloma. Ann Ophthalmol (1982) 0.82
Two primary carcinomas of the lung: adenocarcinoma and a metachronous squamous cell carcinoma. A case report and review of the literature. Cancer (1983) 0.81
Academy of hospice physicians' position statement on access to hospice and palliative care. J Pain Symptom Manage (1996) 0.81
PGE binding in isolated hepatocytes: regulation during fasting. Adv Prostaglandin Thromboxane Leukot Res (1987) 0.81
Inositol glycan phosphate derived from human erythrocyte acetylcholinesterase glycolipid anchor and inositol cyclic 1,2-phosphate antagonize glucagon activation of glycogen phosphorylase. Diabetes (1993) 0.81
Decreased carnitine biosynthesis in rats with secondary biliary cirrhosis. Hepatology (2000) 0.80
Binders to remove uremic waste metabolites from the GI tract. Trans Am Soc Artif Intern Organs (1972) 0.80
Effects of antihypertensive drugs on endocrine function. Drugs (1984) 0.80
Unusual mitochondria in the hepatocytes of rats treated with a vitamin B12 analogue. Anat Rec (1991) 0.80
Effect of ethanol on intracellular ionized calcium concentrations in synaptosomes and hepatocytes. Mol Pharmacol (1987) 0.79
Pasteurella ureae meningitis associated with endocarditis. Report of a case and review of the literature. Eur Neurol (1983) 0.79
Life expectancy, comorbidity, and quality of life. A framework of reference for medical decisions. Clin Geriatr Med (1997) 0.79
Dietary substitution of medium chain triglycerides in subjects with non-insulin-dependent diabetes mellitus in an ambulatory setting: impact on glycemic control and insulin-mediated glucose metabolism. J Am Coll Nutr (1994) 0.79
Inhibition of glucagon-stimulated cAMP accumulation and fatty acid oxidation by E-series prostaglandins in isolated rat hepatocytes. Biochim Biophys Acta (1987) 0.79
Hepatic cobalamin deficiency induced by hydroxycobalamin[c-lactam] treatment in rats is associated with decreased mitochondrial mRNA contents and accumulation of polycistronic mitochondrial RNAs. J Biol Chem (1994) 0.78
Esophageal carcinoma. A six-year review of the Cleveland Veterans Administration Hospital experience. Cancer (1984) 0.78
Separation of acylcarnitines from biological samples using high-performance liquid chromatography. Anal Biochem (1986) 0.78
Transurethral resection in a patient with a dysfibrinogen: fibrinogen cleveland I. J Urol (1977) 0.78
Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. Prostaglandins (1988) 0.78
Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon. Chem Biol Interact (2001) 0.78
Bleeding complications from warfarin anticoagulation in patients with malignancy. J Med (1985) 0.78
Metabolic profiles of cat and rat pharyngeal and diaphragm muscles. Respir Physiol (1996) 0.77
Comparison of high-performance liquid chromatography and a spectrophotometric technique for determining plasma warfarin. J Chromatogr (1978) 0.77
Formal geriatric assessment, An imperative for the older person with cancer. Cancer Pract (1997) 0.77
Effect of atorvastatin on energy expenditure and skeletal muscle oxidative metabolism at rest and during exercise. Clin Pharmacol Ther (2007) 0.77
Long-term changes in gross body composition of paraplegic and quadriplegic patients. Paraplegia (1970) 0.77
Fuel homeostasis and carnitine metabolism in rats with secondary biliary cirrhosis. Hepatology (1991) 0.77
Cancer in persons with inherited blood coagulation disorders. Cancer (1979) 0.77
Fasting-induced changes in prostaglandin binding in isolated hepatocytes and liver plasma membranes. Endocrinology (1987) 0.77
Lysergide treatment of schizophrenic and nonschizophrenic alcoholics: a controlled evaluation. Q J Stud Alcohol (1970) 0.76
On the 10th anniversary of the organization of the American Academy of Hospice and Palliative Medicine (AAHPM): the first 10 years. Am J Hosp Palliat Care (2001) 0.76
Pain management for the geriatric patient. Clin Podiatr Med Surg (1994) 0.76
Acetylcholinesterase inhibition by zifrosilone: pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther (1995) 0.76
Dynamic effects of sinusoidal tilting on heart rate of healthy and paralyzed persons. J Appl Physiol (1969) 0.76
Effect of exogenous carnitine on carnitine homeostasis in the rat. Biochim Biophys Acta (1991) 0.76
Drug-induced electrolyte abnormalities. Drugs (1982) 0.76
Effect of mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188. J Natl Cancer Inst (1988) 0.76
Adsorption: a step toward a wearable artificial kidney. Trans Am Soc Artif Intern Organs (1966) 0.76
A simplified method for monitoring heparin therapy at the bedside: the activated whole blood clotting time. Am J Hematol (1981) 0.75
Effect of propionyl-CoA on enzymic methods for the quantification of acetyl-CoA. Biochem J (1988) 0.75
Symptomatic management of the older person with cancer. Clin Geriatr Med (1997) 0.75
Effect of sodium salicylate on hormonal responses to hypoglycaemia in type II diabetics. Clin Endocrinol (Oxf) (1984) 0.75
Quantification of acylcarnitines. Clin Chem (1985) 0.75
Cytarabine-induced anaphylaxis. Demonstration of antibody and successful desensitization. Arch Intern Med (1980) 0.75
Comparison of local versus central tumor measurements in a multicenter cancer trial. Am J Clin Oncol (1984) 0.75
Phase II evaluation of chlorozotocin in refractory multiple myeloma. Cancer Treat Rep (1984) 0.75
In vivo studies of carnitine and fatty acid metabolism: problems with use of anesthetics. Anal Biochem (1981) 0.75
Binary phase digital reflection holograms: fabrication and potential applications. Appl Opt (1977) 0.75
Granulocytopenia with marked lymphocytosis manifesting Sjogren syndrome. Am J Hematol (1980) 0.75